US - HealthQuill

The Food and Drug Administration has approved Pfizer Inc.’s treatment for metastatic non-small cell lung cancer.

FDA nod for Pfizer’s combination therapy for non-small cell cancer

HQ Team October 12, 2023: The Food and Drug Administration has approved Pfizer Inc.’s treatment for metastatic non-small cell lung cancer. The FDA.

by HealthQuill
October 12, 2023
0 Comments

US and Chinese researchers have developed an artificial intelligence-based platform to predict earthquakes with 70% accuracy.

Climate Health Pharma

US, China, AI developers invent new ways to predict earthquakes

HQ Team October 10, 2023: US and Chinese researchers have developed an artificial intelligence-based platform to predict earthquakes with 70% accuracy. The AI.

by HealthQuill
October 10, 2023
0 Comments

Amgen Inc., a US biotechnology company, completed the acquisition of Horizon Therapeutics Plc for $27.8 billion, gaining access to the Dublin-based firm’s two drugs that treat rare inflammatory diseases.

Drugs Health Pharma

Amgen completes $27.8b acquisition of Horizon Therapeutics

Amgen Inc., a US biotechnology company, completed the acquisition of Horizon Therapeutics Plc for $27.8 billion, gaining access to the Dublin-based firm’s two.

by HealthQuill
October 7, 2023
0 Comments

Hungarian-born biochemist Katalin Kariko and US immunologist Drew Weissman jointly won the Nobel Prize in Physiology or Medicine for their discoveries that led to the development of vaccines to fight the Covid-19 virus.

Drugs Health Pharma

Scientists behind Covid-19 mRNA vaccine bag Nobel medicine prize

HQ Team October 2, 2023: Hungarian-born biochemist Katalin Kariko and US immunologist Drew Weissman jointly won the Nobel Prize in Physiology or Medicine.

by HealthQuill
October 2, 2023
0 Comments

Cordis, a US-based medical device maker, has acquired Switzerland’s MedAlliance for up to $1.1 billion to expand its product portfolio.

Health Medical Pharma

Cordis acquires medical device maker MedAlliance for $1.1 billion

HQ Team October 2, 2023: Cordis, a US-based medical device maker, has acquired Switzerland’s MedAlliance for up to $1.1 billion to expand its.

by HealthQuill
October 2, 2023
0 Comments

Pfizer announced the availability of its migraine management drug Rimegepant in Hong Kong — the company’s first market in Asia.

Drugs Health Pharma

Pfizer enters Hong Kong migraine market, its first in Asia

HQ Team September 29, 2023: Pfizer announced the availability of its migraine management drug Rimegepant in Hong Kong — the company’s first market.

by HealthQuill
September 29, 2023
0 Comments

Using structural and mechanistic information of two parasitic proteins, scientists have built a new component for a vaccine that may induce an immune response to malaria.

Drugs Health Pharma

NIAD develops protein that may help build new malaria vaccine

HQ Team September 28, 2023: Using structural and mechanistic information of two parasitic proteins, scientists have built a new component for a vaccine.

by HealthQuill
September 28, 2023
0 Comments

Higher temperatures have led to a rise in hospital visits for the treatment of alcohol and substance-related disorders in the US.

Climate Health Pharma

US hospitals see alcohol, opioid cases rise due to high temperatures

HQ Team September 27, 2023: Higher temperatures led to a rise in hospital visits for the treatment of alcohol and substance-related disorders in.

by HealthQuill
September 27, 2023
0 Comments

US-based Pacific Northwest National Laboratory, Microsoft Corp., and Micron Technology have joined hands to make computational chemistry available to researchers and industrial users.

Drugs Health Pharma

PNNL ties up with Microsoft, Micron to help lab-to-market path quicker

HQ Team September 21, 2023: US-based Pacific Northwest National Laboratory, Microsoft Corp., and Micron Technology have joined hands to make computational chemistry available.